Perceptive Advisors LLC 13D/13G Filings for CytomX Therapeutics, Inc. (CTMX)

Perceptive Advisors LLC 13D and 13G filings for CytomX Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-16
3:57 pm
Sale
2020-12-3113GCytomX Therapeutics, Inc.
CTMX
Perceptive Advisors LLC2,577,043
4.300%
-676,880decrease
(-20.80%)
Filing